CN Patent

CN106432213A — 作为cftr调节剂的杂芳基衍生物

Assigned to Vertex Pharmaceuticals Inc · Expires 2017-02-22 · 9y expired

What this patent protects

本发明涉及作为CFTR调节剂的杂芳基衍生物，具体涉及ATP结合盒(“ABC”)转运蛋白或其片段的调控剂，包括囊性纤维化跨膜传导调节剂(“CFTR”)、其组合物和及其使用方法。本发明还涉及使用这类调控剂治疗ABC转运蛋白介导的疾病的方法。

USPTO Abstract

本发明涉及作为CFTR调节剂的杂芳基衍生物，具体涉及ATP结合盒(“ABC”)转运蛋白或其片段的调控剂，包括囊性纤维化跨膜传导调节剂(“CFTR”)、其组合物和及其使用方法。本发明还涉及使用这类调控剂治疗ABC转运蛋白介导的疾病的方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN106432213A
Jurisdiction: CN
Classification: —
Expires: 2017-02-22
Drug substance claim: No
Drug product claim: No
Assignee: Vertex Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.